In conclusion, our in vitro and in vivo studies demonstrate that SOX4 regulates Fatty acid metabolism through ChREBP, thereby inhibiting ferroptosis and promoting angiogenesis and tumor growth in HCC. This evidence concerns the gene SOX4 and hepatocellular carcinoma.